Výsledky vyhledávání

The burden of psoriasis in patients with early psoriatic arthritis

Autor: Jolanda J. Luime, Marc R. Kok, Fazira R Kasiem, Marijn Vis, Lindy-Anne Korswagen, Faouzia Fodili, Nastasja H A M Denissen, Maikel van Oosterhout, Johanna M. W. Hazes, K. Wervers, Ilja Tchetverikov, Cicero, Yvonne P M Goekoop-Ruiterman

Publikováno v: Rheumatology (United Kingdom), 61(4), 1570-1578. Oxford University Press

Objectives Psoriasis impacts health-related quality of life (HRQoL) in PsA patients. However, this is not adequately measured with a general HRQoL questionnaire. The aim of this study was to quantify the degree of psoriasis evolution in PsA patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27c06cc81023b4c22c8f72424b827a0
https://doi.org/10.1093/rheumatology/keab606

Zobrazit plný text záznamu

POS1054 PAIN AND DEPRESSION ARE ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN PATIENTS WITH PSORIATIC ARTHRITIS

Autor: F. R. Kasiem, L. Tucker, M. Vis, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, L. Coates, M. R. Kok

Publikováno v: Annals of the Rheumatic Diseases. 81:847.1-847

BackgroundPsoriatic arthritis (PsA) is a heterogeneous, immune-mediated inflammatory arthritis. Methotrexate (MTX) is the first-line treatment in PsA patients, despite diverse clinical phenotypes and highly varied responses(1). As yet, it is not poss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b8376b000bd69b4f320abf70fa49b1a
https://doi.org/10.1136/annrheumdis-2022-eular.2762

Zobrazit plný text záznamu

POS1084 IMPACT OF PSORIASIS REMAINS IMPORTANT IN PSORIATIC ARTHRITIS PATIENTS WITH LOW MUSCULOSKELETAL DISEASE ACTIVITY

Autor: F. R. Kasiem, M. R. Kok, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, M. Vis

Publikováno v: Annals of the Rheumatic Diseases. 81:868.2-869

BackgroundPsoriatic arthritis (PsA) is a complex, chronic auto-immune disease that affects health-related Quality of Life (HRQoL). Earlier research showed that general HRQoL in PsA patients is mainly affected by musculoskeletal pain.1 However, psoria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dae68f9583b340c69dd9add20f9c54b9
https://doi.org/10.1136/annrheumdis-2022-eular.2639

Zobrazit plný text záznamu

Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

Autor: Erik Lubberts, Marijn Vis, Priyanka S Bangoer, Johanna M. W. Hazes, Marc R. Kok, Ilja Tchetverikov, Adriana M. C. Mus, Nadine Davelaar, Jolanda J. Luime, K. Wervers, Hannah den Braanker

Publikováno v: RMD Open, 6(2):e001175. BMJ Publishing Group
RMD Open
RMD Open, Vol 6, Iss 2 (2020)

ObjectivesMethotrexate (MTX) is currently the recommended first-line therapy for treating psoriatic arthritis (PsA), despite lacking clear evidence. No estimates of efficacy of MTX in usual care and no clear MTX responsive clinical or laboratory vari

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d8580c9e9803bc61bb2d5fe543ad56
https://pure.eur.nl/en/publications/37f69860-75f2-4354-a73a-e2b6743fec8b

Zobrazit plný text záznamu

Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study

Autor: Ilja Tchetverikov, F. R. Kasiem, L-A Korswagen, W.L. van der Graaff, Jhlm van Groenendael, Ypm Goekoop-Ruiterman, K. Wervers, Mjf Starmans-Kool, Jolanda J. Luime, JJ Veris-van Dieren, Kok, Jmw Hazes, C. Appels, Marijn Vis, Andreas H. Gerards

Objective: This paper describes the baseline demographics, clinical characteristics, and patient-reported outcomes (PROs) according to clinical phenotype of patients with early psoriatic arthritis (PsA) for the purpose of creating a decision support

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25774d1997a933ac39a6c73ee79ab25

Zobrazit plný text záznamu

Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers

Autor: Marijn Vis, Andreas H. Gerards, N. Rasappu, M. van der Ven, K. Wervers, Ilja Tchetverikov, Johanna M. W. Hazes, Jolanda J. Luime, Marc R. Kok

Publikováno v: Scandinavian Journal of Rheumatology, 47(4), 291-294. Informa Healthcare

Objectives: We aimed to describe sonographic structural and inflammatory changes in entheses of patients with recently diagnosed psoriatic arthritis (PsA), patients with established PsA, and young healthy volunteers, and to investigate whether the MA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a137787f3a47a01bd1e7092a7b92bea
https://doi.org/10.1080/03009742.2017.1393695

Zobrazit plný text záznamu

Plný text ve formátu HTML

Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis

Autor: K. Wervers, Cathelijne W. Y. Appels, Johanna M. W. Hazes, Lindy-Anne Korswagen, Marijn Vis, Josien J. Veris-van Dieren, Wiebo L. van der Graaff, Marc R. Kok, Johannes H L M van Groenendael, Andreas H. Gerards, Ilja Tchetverikov, Jolanda J. Luime

Publikováno v: Journal of Rheumatology, 45(11), 1526-1531. Journal of Rheumatology

Objective.Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses, and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We aim to assess HRQOL in patients newly diagnosed with PsA an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db68cb59e147eed0da1879f219e125b
https://pure.eur.nl/en/publications/88ab431e-c0ee-4fa1-96a1-d131ee10c826

Zobrazit plný text záznamu

SAT0401 USE OF AND RESPONSE TO METHOTREXATE IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE REAL WORLD COHORT, DEPAR STUDY

Autor: K. Wervers, Wiebo L. van der Graaff, Marijn Vis, Josien J. Veris-van Dieren, Marc R. Kok, Johanna M. W. Hazes, Hannah den Braanker, Cathelijne W. Y. Appels, Cicero, Lindy-Anne Korswagen, Andreas H. Gerards, Hans van Groenendael, Ilja Tchetverikov, Jolanda J. Luime

Publikováno v: Saturday, 15 June 2019.

Background: Methotrexate (MTX) is the preferred drug of most rheumatologists for treating psoriatic arthritis (PsA). Despite its widespread use in clinical practice, scientific evidence of methotrexate on the different manifestations of psoriatic dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae950a14d5ff5d785bcb1329b93ab7e0
https://doi.org/10.1136/annrheumdis-2019-eular.5371

Zobrazit plný text záznamu

AB0786 IMPACT OF PSORIASIS SEVERITY ON HEALTH-RELATED QUALITY OF LIFE IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM REAL WORLD DATA, THE DEPAR STUDY

Autor: J. M. W. Hazes, Marijn Vis, Jolanda J. Luime, Marc R. Kok, F. R. Kasiem, K. Wervers, Ilja Tchetverikov

Publikováno v: Annals of the Rheumatic Diseases. 79:1691.2-1692

Background:Psoriasis is an important feature of psoriatic arthritis (PsA). Psoriasis itself is known to have a significant impact on Health-related Quality of life (HRQoL)1, however its role within PsA is less well understood. In daily practice, asse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4d554ed7c28493fe29101ae2adc59d1
https://doi.org/10.1136/annrheumdis-2020-eular.3062

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání